Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $381.34 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $221.53 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $122.13 | 3 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $13.26 | 1 | $0 (2018) |
| PFIZER INC. | $12.43 | 1 | $0 (2017) |
| Allergan Inc. | $11.99 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $25.25 | 2 | AstraZeneca Pharmaceuticals LP ($13.26) |
| 2017 | $356.09 | 6 | Genentech USA, Inc. ($221.53) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/10/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/22/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/20/2017 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $96.54 | General |
| 11/28/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $8.47 | General |
| Category: Cardiovascular | ||||||
| 11/21/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2017 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Metabolism & Primary Care | ||||||
| 10/17/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $106.75 | General |
| Category: Cardiovascular | ||||||
| 01/10/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.91 | General |
| Category: Cardiovascular | ||||||
About Dr. Lawrence Moloff, MD
Dr. Lawrence Moloff, MD is a Emergency Medicine healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508863861.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Moloff, MD has received a total of $381.34 in payments from pharmaceutical and medical device companies, with $25.25 received in 2018. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($381.34).
Practice Information
- Specialty Emergency Medicine
- Location Syracuse, NY
- Active Since 07/01/2005
- Last Updated 06/12/2008
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1508863861
Products in Payments
- ELIQUIS (Drug) $134.56
- Activase (Biological) $124.99
- BRILINTA (Drug) $13.26
- TEFLARO (Drug) $11.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Syracuse
David Mason, Md, MD
Emergency Medicine — Payments: $1,580
Ross Sullivan, Md, MD
Emergency Medicine — Payments: $1,510
Fouad Boulos, Md, MD
Emergency Medicine — Payments: $878.53
Mark Stever, Rpa, RPA
Emergency Medicine — Payments: $860.86
Kevin Stimson, M.d, M.D
Emergency Medicine — Payments: $546.44
Richard Steinmann, Md, MD
Emergency Medicine — Payments: $544.35